Author

E. Qing

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

T. Gallagher· 3 shared A. E. Merrill· 1 shared A. Odle· 1 shared A. R. Rojas Chavez· 1 shared B. Doray· 1 shared B. G. Pierce· 1 shared B. Jennings· 1 shared C. Han· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

T. Gallagher

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning

R. Lei, E. Qing, A. Odle, M. Yuan, T. J. C. Tan, N. So, W. O. Ouyang, I. A. Wilson, T. Gallagher, S. Perlman, N. C. Wu, L. Y. R. Wong

This study uses deep mutational scanning to analyze the SARS-CoV-2 spike fusion peptide, identifying mutations affecting viral entry and antibody resistance.

bioRxiv · Nov 28, 2023Microbiology

A single C-terminal residue controls SARS-CoV-2 spike trafficking and virion assembly

D. Dey, E. Qing, Y. He, Y. Chen, B. Jennings, W. Cohn, S. Singh, L. Gakhar, N. J. Schnicker, B. G. Pierce, J. P. Whitelegge, B. Doray, J. P. Orban, T. Gallagher, S. S. Hasan

This study identifies a C-terminal residue critical for SARS-CoV-2 spike protein trafficking and virion assembly, offering insights for vaccine design.

bioRxiv · Mar 9, 2023 · PreprintBiophysics

Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein

H. A. Van Ert, D. W. Bohan, K. J. Rogers, M. Fili, A. R. Rojas Chavez, E. Qing, C. Han, S. M. Dempewolf, G. Hu, N. Schwery, K. M. Sevcik, N. Ruggio, D. Boyt, M. Pentella, T. Gallagher, , H. Haim

The paper analyzes antibody responses in SARS-CoV-2-infected individuals, finding limited variation in domain specificity and relative neutralization potency across subjects.

bioRxiv · Aug 4, 2021Microbiology